Genscript Biotech Corporation
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 36.59 | -100% | -262.31 | -100% |
| P/S |
|
6.18 | 7.13 | -13.34% |
|
|
| P/BV |
|
2.54 | 3.66 | -30.55% |
|
|
| P/FCF |
|
-94.03 | -11.82 | 695.83% |
|
|
| Ev/Ebitda |
|
-93.49 | 2.91 | -3315.04% |
|
|
| Ev/S |
|
39.44 | 16.44 | 139.93% |
|
|
| Ev/FCF |
|
-74.47 | -7.89 | 844.23% |
|
|
| E/P |
|
-0.0023 | 0.0325 | -107.09% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-42.19 | -9.7 | 334.93% | -56.8 | -25.72% |
| ROE |
|
-7.95 | 4.42 | -279.94% |
|
|
| ROA |
|
-3.22 | 2.95 | -209.13% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-11.37 | -11.15 | 1.99% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.85 | 0.7677 | -341.25% | -2.65 | -30.1% |
| Nеt Debt/Ebitda |
|
0 | 0.0174 | -100% |
|
|
| Debt/Ratio |
|
0.1937 | 0.1212 | 59.74% |
|
|
| Debt/Equity |
|
1.01 | 0.8042 | 26.09% |
|
|
| Debt/Net Income |
|
-6.87 | 1.54 | -547.08% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.7 | -100% | 0.1972 | -100% |
| Number of years of dividend growth |
|
1 | 1.13 | -11.11% | ||
| DSI |
|
0.5 | 0.5838 | -14.35% |
|
|
| Average dividend growth |
|
0 | 3.2 | -100% |
|
|
| Average percentage for 5 years |
|
0.1972 | 4.95 | -96.02% |
|
|
| Average percentage for payments |
|
19.33 | 24.82 | -22.12% |
|
|
| Difference from average difference in sector |
|
-5.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-60.42 | 1.85 | -3365.95% | ||
| Growth impulse Ebitda in 5 years |
|
-309.46 | -44.43 | 596.51% | ||
| Growth impulse Net Income in 5 years |
|
-87.31 | 58.07 | -250.35% | ||
| Growth impulse FCF in 5 years |
|
201.37 | -7.48 | -2792.11% | ||
| Growth impulse EPS in 5 years |
|
-98.56 | -198.43 | -50.33% |
IP Score
2.98/10
